Artificial Intelligence Expands in Cardiology and Surgical Care Markets

A market research report projects the global artificial intelligence (AI) market for cardiology to grow from $2.2 billion in 2025 to $14.22 billion by 2035, driven by rising cardiovascular disease prevalence, aging populations, and the need for faster, more accurate diagnosis. The report cites major players such as GE Healthcare, Philips, and other technology firms developing AI tools for ECG, imaging, and predictive analytics.

In Japan, the startup ANOUT has introduced the AI‑based surgical assistance system EUREKA, which visualizes hard‑to‑see tissue structures in real time during operations. Approved in 2024, EUREKA α now supports procedures on the stomach, colon, pancreas, and gynecological surgeries, and the company is expanding the technology to endoscopy, robotic assistance, and international markets, having secured a UK certification and opened a U.S. subsidiary.